Yazar "Ersöz, Deniz Doğru" için listeleme
-
Cystic fibrosis patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
Çobanoğlu, Fatma Nazan; Ersöz, Deniz Doğru; Çakır, Erkan; Eyuboğlu, Tuğba; Pekcan, Sevgi; Cinel, Güzin; Yalçın, Ebru; Can, Demet (European Respiratory Soc Journals Ltd, 2019)Better understanding of CFTR biology has led to the development of modulator drugs. Lumacaftor/Ivacaftor (L/T) is approved for people ages ≥2 who have two copies of the F508del mutation. Tezacaftor/Ivacaftor (T/I) is ...